BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20934245)

  • 1. Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α.
    Jang SY; Jang SW; Ko J
    Cancer Lett; 2011 Jan; 300(1):57-65. PubMed ID: 20934245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
    Jang EH; Jang SY; Cho IH; Hong D; Jung B; Park MJ; Kim JH
    Biochem Biophys Res Commun; 2015 Aug; 463(4):917-22. PubMed ID: 26056942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α.
    Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
    Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9.
    Mi C; Shi H; Ma J; Han LZ; Lee JJ; Jin X
    Oncol Rep; 2014 Dec; 32(6):2527-32. PubMed ID: 25310109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer.
    Liu X; Hu Q; Wang W; Ma H; Pu J; Cui J; Gong T; Wu Y; Lu W; Huang J
    Biochem Pharmacol; 2021 Jun; 188():114583. PubMed ID: 33915156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
    Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
    Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.
    Kim Y; Kang H; Jang SW; Ko J
    Cell Physiol Biochem; 2011; 28(2):175-84. PubMed ID: 21865725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling.
    Hu Y; Qi Y; Liu H; Fan G; Chai Y
    Biochim Biophys Acta; 2013 Mar; 1830(3):2779-89. PubMed ID: 23142250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.
    Mou H; Zheng Y; Zhao P; Bao H; Fang W; Xu N
    Toxicol In Vitro; 2011 Aug; 25(5):1027-32. PubMed ID: 21466843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway.
    Hwang ST; Yang MH; Baek SH; Um JY; Ahn KS
    Life Sci; 2020 Dec; 263():118594. PubMed ID: 33075375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].
    Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
    Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
    Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
    Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
    Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
    Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
    Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.